Hron G - Search Results

1

Prognostic value of T-cell receptor gamma rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas.

Schützinger C, Esterbauer H, Hron G, Skrabs C, Uffmann M, Raderer M, Hauswirth A, Mannhalter C, Dieckmann K, Wagner O, Formanek M, Stift A, Friedl J, Gaiger A, Chott A, Jäger U. Schützinger C, et al. Among authors: hron g. Leuk Lymphoma. 2008 Feb;49(2):237-46. doi: 10.1080/10428190701784409. Leuk Lymphoma. 2008. PMID: 18231909

2

Circulating P-selectin and the risk of recurrent venous thromboembolism.

Kyrle PA, Hron G, Eichinger S, Wagner O. Kyrle PA, et al. Among authors: hron g. Thromb Haemost. 2007 Jun;97(6):880-3. Thromb Haemost. 2007. PMID: 17549288

3

Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.

Gulesserian T, Hron G, Endler G, Eichinger S, Wagner O, Kyrle PA. Gulesserian T, et al. Among authors: hron g. Thromb Haemost. 2006 Jan;95(1):65-7. Thromb Haemost. 2006. PMID: 16543963 Clinical Trial.

4

Overweight, obesity, and the risk of recurrent venous thromboembolism.

Eichinger S, Hron G, Bialonczyk C, Hirschl M, Minar E, Wagner O, Heinze G, Kyrle PA. Eichinger S, et al. Among authors: hron g. Arch Intern Med. 2008 Aug 11;168(15):1678-83. doi: 10.1001/archinte.168.15.1678. Arch Intern Med. 2008. PMID: 18695082

5

Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer.

Hron G, Kollars M, Weber H, Sagaster V, Quehenberger P, Eichinger S, Kyrle PA, Weltermann A. Hron G, et al. Thromb Haemost. 2007 Jan;97(1):119-23. Thromb Haemost. 2007. PMID: 17200778

6

Tissue factor exposing microparticles in inflammatory bowel disease.

Palkovits J, Novacek G, Kollars M, Hron G, Osterode W, Quehenberger P, Kyrle PA, Vogelsang H, Reinisch W, Papay P, Weltermann A. Palkovits J, et al. Among authors: hron g. J Crohns Colitis. 2013 Apr;7(3):222-9. doi: 10.1016/j.crohns.2012.05.016. Epub 2012 Jun 15. J Crohns Colitis. 2013. PMID: 22705067

7

Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time.

Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA. Hron G, et al. J Thromb Haemost. 2006 Apr;4(4):752-6. doi: 10.1111/j.1538-7836.2006.01868.x. J Thromb Haemost. 2006. PMID: 16634742 Free article.

8

Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation.

Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Hron G, et al. JAMA. 2006 Jul 26;296(4):397-402. doi: 10.1001/jama.296.4.397. JAMA. 2006. PMID: 16868297 Free article.

9

Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans.

Lubsczyk B, Kollars M, Hron G, Kyrle PA, Weltermann A, Gartner V. Lubsczyk B, et al. Among authors: hron g. Eur J Clin Invest. 2010 Jun;40(6):477-82. doi: 10.1111/j.1365-2362.2010.02299.x. Epub 2010 Apr 26. Eur J Clin Invest. 2010. PMID: 20456486 Clinical Trial.

10

Family history for venous thromboembolism and the risk for recurrence.

Hron G, Eichinger S, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Stain M, Gartner V, Kyrle PA. Hron G, et al. Am J Med. 2006 Jan;119(1):50-3. doi: 10.1016/j.amjmed.2005.04.043. Am J Med. 2006. PMID: 16431184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters